Laboratory Corporation of America Holdings (LH)

Operating profit margin

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Operating income (ttm) US$ in thousands 1,086,700 747,400 745,600 717,100 725,600 1,214,300 1,336,000 1,498,500 1,856,600 2,221,300 2,614,200 2,889,500 3,259,500 3,822,100 4,102,300 3,695,900 2,445,400 1,488,600 781,400 819,400
Revenue (ttm) US$ in thousands 13,008,900 12,712,800 12,487,600 12,300,400 12,161,600 15,070,900 14,880,900 14,770,200 15,632,000 13,745,500 14,941,300 15,859,000 16,120,900 16,554,600 16,388,100 15,316,200 13,978,500 12,442,100 11,474,500 11,587,400
Operating profit margin 8.35% 5.88% 5.97% 5.83% 5.97% 8.06% 8.98% 10.15% 11.88% 16.16% 17.50% 18.22% 20.22% 23.09% 25.03% 24.13% 17.49% 11.96% 6.81% 7.07%

December 31, 2024 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $1,086,700K ÷ $13,008,900K
= 8.35%

The operating profit margin of Laboratory Corporation of America Holdings has shown fluctuations over the period under review. Starting at 7.07% in March 2020, the margin decreased slightly to 6.81% by June 2020. Subsequently, there was a significant improvement in profitability, with the margin reaching 17.49% by December 2020.

The positive trend continued into 2021, with a notable increase in the operating profit margin to 25.03% by June 2021. However, there was a slight decline in the margin to 16.16% by September 2022. The margin further decreased to 5.97% by December 2023.

In the last quarter of 2024, there was a recovery in the operating profit margin, which stood at 8.35%. Overall, the operating profit margin of Laboratory Corporation of America Holdings has displayed variability over the analyzed period, with both peaks and troughs in profitability levels.


Peer comparison

Dec 31, 2024

Company name
Symbol
Operating profit margin
Laboratory Corporation of America Holdings
LH
8.35%
Fortrea Holdings Inc.
FTRE
-6.12%
Fulgent Genetics Inc
FLGT
-67.61%
Quest Diagnostics Incorporated
DGX
13.87%
RadNet Inc
RDNT
5.74%